Cancer Epidemiology and Prevention
A section of Cancers (ISSN 2072-6694).
Section Information
Despite the great advances made in cancer therapy, prevention remains the cornerstone for diminishing cancer mortality. Accordingly, increasing epidemiology knowledge is crucial for identifying adequate preventive measures. Many efforts have been made to understand what is causing a specific cancer and epidemiology has been essential to guide further studies on the pathophysiology of cancers. Knowing the cancer incidence trends and the risk factors for developing a specific cancer is of unvaluable help for designing strategies that try to increase early detection, ideally at a curative stage. Moreover, this knowledge contributes to develop healthy behaviors that might eventually decrease cancer incidence.
In this section are included studies providing new insights into cancer epidemiology and prevention, mainly offering substantial information that can be used in the prevention of cancer. We particularly encourage the submission of meta-analyses, systematic reviews, and prospective studies, although well designed case-control studies are also acceptable.
The topics for section include, but are not limited to:
- Primary prevention;
- Secondary prevention;
- Epidemiology;
- Risk factors;
- Cancer incidence;
- Cancer prevalence;
- Gene–environmental interaction;
- Genetic epidemiology;
- Population awareness;
- Preventive campaigns.
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- The Anglesio Prize in Cancer Epidemiology and Cancer Registration (Deadline: 30 April 2024)
- Gynecologic Cancer: Risk Factors, Interception and Prevention (Deadline: 20 May 2024)
- Cancer and Nutrients (Deadline: 20 May 2024)
- Understanding the Role of Diet, Nutrition and Body Composition in Cancer Survivorship (Deadline: 30 May 2024)
- Viruses in Cancer Etiology (Deadline: 31 May 2024)
- Side Effects of Anticancer Therapy: Prevention and Management (Deadline: 31 May 2024)
- Advances in Survival of Glioblastoma (Deadline: 1 June 2024)
- Thyroid Cancer: Incidence and Risk Factors (Deadline: 15 June 2024)
- Study on Epidemiology of Childhood Cancer (Deadline: 15 June 2024)
- Mesothelioma Epidemiology, Pathogenesis, Emerging Treatments and Pre-Clinical Models (Deadline: 25 June 2024)
- Genomic, Epigenomic, and Transcriptomic Landscapes of Brain Cancers (Deadline: 30 June 2024)
- Helicobacter pylori Infection and the Development of Gastric Cancer (Deadline: 30 June 2024)
- Oral Cancer and COVID-19 (Deadline: 1 July 2024)
- Emerging Trends in Global Cancer Epidemiology (Deadline: 1 July 2024)
- Rethinking Cancer Epidemiology, Aging and Machine Learning (Deadline: 31 July 2024)
- New Era of Cancer Research: From Large-Scale Cohorts to Big-Data (Deadline: 10 August 2024)
- Inherited Breast Cancer Risk: BRCA Mutations and Beyond (Deadline: 20 August 2024)
- Skin Cancer and Environmental Exposure (Deadline: 25 August 2024)
- Oral Cancer: Prevention and Early Detection (Deadline: 31 August 2024)
- Study on HPV-Associated Oropharyngeal Cancer (Deadline: 31 August 2024)
- Recent Advances in Trachea, Bronchus and Lung Cancer Management (Deadline: 15 September 2024)
- Risk for Cancer-Associated Thrombosis (Deadline: 15 September 2024)
- Obesity and Cancers (Deadline: 30 September 2024)
- The Genetics, Epidemiology, and Early Detection of Brain Cancers (Deadline: 30 September 2024)
- Head and Neck Cancer: Epidemiology, Prevention, Treatment, and Quality of Life (Deadline: 30 September 2024)
- Clinical Epidemiology and Risk Prediction for Gastrointestinal Cancers (Deadline: 1 October 2024)
- Mitochondrial Functions in Cancer (Deadline: 1 October 2024)
- Colorectal Cancer: Epidemiology and Prevention (Deadline: 10 October 2024)
- Development and Application of Models to Predict Cancer Incidence and Prevalence (Deadline: 15 October 2024)
- Recent Advances in Skin Cancers (Deadline: 17 October 2024)
- Inflammation in Cancers (Deadline: 25 October 2024)
- Health Services Research in Cancer Care (Deadline: 31 October 2024)
- Gastrointestinal Malignancy: Epidemiology and Risk Factors (Deadline: 15 November 2024)
- Skin Cancer: Risk Factors and Prevention (Deadline: 30 November 2024)
- Novel Strategies in the Prevention/Treatment of Colorectal Cancer (Deadline: 30 November 2024)
- Recent Advances in Colorectal Cancer Screening (Deadline: 1 December 2024)
- Advances in Oral Cancers and Precancers (Deadline: 10 December 2024)
- Current Epidemiologic, Diagnostic, and Therapeutic Aspects of Cholangiocarcinoma (CCA) (Deadline: 20 December 2024)
- Feature Paper in Section 'Cancer Epidemiology and Prevention' in 2024 (Deadline: 31 December 2024)
- Chemical Carcinogenesis in Skin Cancers (Deadline: 31 December 2024)
- Disparities in Cancer Prevention, Screening, Diagnosis and Management (Deadline: 31 December 2024)
- How COVID-19 Affects Cancer Patients (Deadline: 30 January 2025)
- Advances in Bladder Preservation Approaches for Bladder Cancer (Volume II) (Deadline: 28 February 2025)
- The Impact of Community Context and Cancer Disparities (Deadline: 31 May 2025)
- New Concepts and Recent Advances in the Management of Skin Cancer (Deadline: 31 August 2025)
- What’s behind the Scenes? New Insights in Endometrial Cancer Management and Risk Stratification (Deadline: 20 October 2025)
Topical Collections
Following topical collections within this section are currently open for submissions:
